Aldeyra Therapeutics, Inc.
2019 Q4 - 2025 Q4 (17 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 17 | 0.0% | 3,341 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 19 | 0.0% | 3,613 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 14 | 0.0% | 3,610 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 21 | 0.0% | 3,610 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 18 | 0.0% | 3,610 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 19 | 0.0% | 3,610 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 12 | 0.0% | 3,610 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 15 | 0.0% | 4,682 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 27 | 0.0% | 7,666 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 345 | 0.0% | 51,697 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 476 | 0.0% | 56,712 | 6/30/2023 |
| 2022 Q1 | 5/16/2022 | 93 | 0.0% | 20,956 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 105 | 0.0% | 26,203 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 230 | 0.0% | 26,203 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 759 | 0.0% | 66,960 | 6/30/2021 |
| 2020 Q1 | 5/13/2020 | 87 | 0.0% | 35,132 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 202 | 0.0% | 34,724 | 12/31/2019 |